IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12

被引:129
|
作者
Lieberman, LA
Cardillo, F
Owyang, AM
Rennick, DM
Cua, DJ
Kastelein, RA
Hunter, CA
机构
[1] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA
[2] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil
[3] DNAX Res Inst Molec & Cellular Biol Inc, Discovery Res, Palo Alto, CA 94304 USA
来源
JOURNAL OF IMMUNOLOGY | 2004年 / 173卷 / 03期
关键词
D O I
10.4049/jimmunol.173.3.1887
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-23 and IL-12 are heterodimeric cytokines which share the p40 subunit, but which have unique second subunits, IL-23p19 and IL-12p35. Since p40 is required for the development of the Th1 type response necessary for resistance to Toxoplasma gondii, studies were performed to assess the role of IL-23 in resistance to this pathogen. Increased levels of IL-23 were detected in mice infected with T. gondii and in vitro stimulation of dendritic cells with this pathogen resulted in increased levels of mRNA for this cytokine. To address the role of IL-23 in resistance to T. gondii, mice lacking the p40 subunit (common to IL-12 and IL-23) and mice that lack IL-12 p35 (specific for IL-12) were infected and their responses were compared. These studies revealed that p40(-/-) mice rapidly succumbed to toxoplasmosis, while p35(-/-) mice displayed enhanced resistance though they eventually succumbed to this infection. In addition, the administration of IL-23 to p40(-/-) mice infected with T. gondii resulted in a decreased parasite burden and enhanced resistance. However, the enhanced resistance of p35(-/-) mice or p40(-/-) mice treated with IL-23 was not associated with increased production of IFN-gamma. When IL-23p19(-/-) mice were infected with T. gondii these mice developed normal T cell responses and controlled parasite replication to the same extent as wild-type mice. Together, these studies indicate that IL-12, not IL-23, plays a dominant role in resistance to toxoplasmosis but, in the absence of IL-12, IL-23 can provide a limited mechanism of resistance to this infection.
引用
收藏
页码:1887 / 1893
页数:7
相关论文
共 50 条
  • [21] Elevated expression of IL-12 and IL-23 in patients with aplastic anemia
    Gu, Y.
    Zhang, J.
    Peng, J.
    Hu, X.
    Xu, C.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2009, 31 (02) : 207 - 214
  • [22] IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
    Verstockt, Bram
    Salas, Azucena
    Sands, Bruce E.
    Abraham, Clara
    Leibovitzh, Haim
    Neurath, Markus
    Vande Casteele, Niels
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (07) : 433 - 446
  • [23] IL-23 and IL-12 responses in activated human T cells retrovirally transduced with IL-23 receptor variants
    de Paus, Roelof A.
    van de Wetering, Diederik
    van Dissel, Jaap T.
    van de Vosse, Esther
    [J]. MOLECULAR IMMUNOLOGY, 2008, 45 (15) : 3889 - 3895
  • [24] IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
    Bram Verstockt
    Azucena Salas
    Bruce E. Sands
    Clara Abraham
    Haim Leibovitzh
    Markus F. Neurath
    Niels Vande Casteele
    [J]. Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 433 - 446
  • [25] IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting
    Moschen, Alexander R.
    Tilg, Herbert
    Raine, Tim
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (03) : 185 - 196
  • [26] IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting
    Alexander R. Moschen
    Herbert Tilg
    Tim Raine
    [J]. Nature Reviews Gastroenterology & Hepatology, 2019, 16 : 185 - 196
  • [27] IL-12 independent mechanisms of resistance during T-gondii infection:: A role for IL-23?
    Lieberman, LA
    Cardillo, F
    Rennick, D
    Hunter, CA
    [J]. FASEB JOURNAL, 2002, 16 (05): : A1068 - A1068
  • [28] IL-12/IL-23 inhibitors: a promising approach to the treatment of inflammatory disorders
    Wada, Yumiko
    [J]. DRUGS OF THE FUTURE, 2008, 33 (01) : 49 - 63
  • [29] Ovarian follicular concentration of IL-12, IL-15, IL-18 and p40 subunit of IL-12 and IL-23
    Vujisic, Sanja
    Lepej, Snjezana Zidovec
    Emedi, Ivana
    Bauman, Renato
    Remenar, Anica
    Tiljak, Mirjana Kujundzic
    [J]. HUMAN REPRODUCTION, 2006, 21 (10) : 2650 - 2655
  • [30] Neutralization of IL-12 and IL-23 does not prevent experimental alopecia areata
    Ortolan, L.
    Crotts, S.
    Jabbari, A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S18 - S18